Clinical Trial

Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to learn about the efficacy and safety of PRT-064040 Nasal Spray versus placebo in the acute treatment of moderate or severe migraine.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-12.
Status change: Not Yet Recruiting → Recruiting 2026-01-27
Trial Details
NCT Number NCT07304518
Lead Sponsor Sichuan Purity Pharmaceutical Technology Co., Ltd.
Conditions Migraine
Enrollment 456 participants
Start Date 2026-01-26
Primary Completion 2026-09 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-01-29